Nuclear Imaging

Molecular imaging, also called nuclear imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI.

Dr. Michael Butkus is Co-medical Director and Head of Proton Physics at the Dwoskin Proton Center at the Sylvester Comprehensive Cancer Center

Feature | Proton Therapy | By Christine Book

One on One … with Michael Butkus, PhD

A University of Miami Radiation Oncology department summary noted: “In radiation oncology, the art of patient care meets ...

October 11, 2023

Videos | Proton Therapy

VIDEO: Advancements in Proton Therapy

Tune in to ITN’s latest “One on One” video series with Michael Butkus, PhD, for insights into proton therapy ...

October 10, 2023

Technology-powered collaboration aims to deliver AI-enabled devices and digital solutions at the enterprise level to increase clinical and operational efficiencies, drive workflow enhancements and improve patient outcomes

News | Radiology Business

GE HealthCare and University Hospitals Enter 10-Year Strategic Collaboration to Contemporize Its Imaging Fleet and Implement Enterprise Digital Solutions to Help Improve Patient Care and Optimize Processes

October 10, 2023 — Realizing a vision to deliver the best care to patients close to where they live in northern Ohio, GE ...

October 10, 2023

Sponsored Content

Staging F-18 FDG PET/CT images of adenocarcinoma in the RUL of the lung illustrates the value of Vereos. The primary lesion in the right upper lobe appears in the upper row (PET image is left, CT image is right). A 3 mm synchronous primary or metastatic lesion in the RUL is apparent in the lower row. The precision afforded by Vereos' images provided the basis for the patient to undergo RUL lobectomy instead of thermal ablation of the primary lesion. Images courtesy of Dr. Jay Kikut and UVM

Blog | PET-CT

Digital PET Balances Scan Time and Resolution

Efficiency and effectiveness are inseparable in clinical medicine. Digital PET addresses them both. The key is the ...

October 25, 2018

POSLUMA (flotufolastat F 18) PET/CT image showing uptake in the prostate gland, consistent with primary prostate cancer.

News | Radiopharmaceuticals and Tracers

Additional Results of POSLUMA (Flotufolastat F 18) Performance in Newly Diagnosed, High-risk Prostate Cancer Patients Presented at ASTRO

October 5, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

October 05, 2023

Advancements in research, technology and partnerships are combining to enhance availability and access

Feature | Proton Therapy | By Christine Book

Targeting Cancer, Tracking Collaboration: A Progress Report on Proton Therapy

An overview of significant developments in proton therapy, over just the past six months, reinforces the pace of ...

September 21, 2023

A the COVID-19 public health emergency continues to evolve, SNMMI issues updated guidance

News | SNMMI

SNMMI Issues Updated Statement: COVID-19 and V/Q Lung Studies

September 18, 2023 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI), as a professional society ...

September 18, 2023

NorthStar’s high purity non-carrier added (n.c.a.) Ac-225 to be used in Curadh’s molecularly targeted radiation (MTR) programs for treatment of solid tumors

News | Radiopharmaceuticals and Tracers

NorthStar Medical Radioisotopes and Curadh MTR Announce a Strategic Long Term Supply Agreement for Therapeutic Radioisotope Actinium-225 (Ac-225)

August 31, 2023 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

August 31, 2023

First participant of cohort 4 of the theranostic CL04 trial investigating 64Cu/67Cu SARTATE in neuroblastoma has been treated at the highest dose cohort of 375MBq/kg body weight using NorthStar’s electron accelerator-produced Cu-67, marking a key milestone in NorthStar’s agreement to exclusively supply Cu-67 to Clarity

News | Radiopharmaceuticals and Tracers

First Participant Treated Using NorthStar Medical Radioisotopes’ Electron Accelerator-produced Copper-67 (Cu-67) in Clarity Pharmaceuticals’ Phase I/IIa Theranostic Clinical Trial Investigating Cu-67 SARTATE for Treatment of Neuroblastoma

August 29, 2023 — NorthStar Medical Radioisotopes, LLC (“NorthStar"), a global innovator in the development, production ...

August 29, 2023

News | Radiopharmaceuticals and Tracers

Carolina Breast Imaging Specialists, PLLC Is First in Nation to Adopt Groundbreaking Imagio Breast Imaging System for Breast Cancer Diagnosis

August 29, 2023 — Mammograms are an essential part of preventive healthcare, and when an initial review reveals a ...

August 29, 2023

Radiopharmaceutical-directed treatment ushers in a new era of autonomous radiotherapy

News | Radiation Therapy

World’s First Cancer Patient Treated with RefleXion’s Breakthrough SCINTIX Biology-guided Radiotherapy

August 23, 2023 — RefleXion Medical, a therapeutic oncology company, today announced that the first patient has ...

August 23, 2023

Study investigated impact of radiographic media contrast shortage on stroke patient scan data

News | Contrast Media

Researchers Discover Contrast Dye Shortage Affected Assessment of Stroke Patients

August 17, 2023 — University of Missouri School of Medicine neurologist Adnan Qureshi, MD recently led a study that ...

August 17, 2023

In elderly patients with suspected prostate cancer, PSMA PET/CT can diagnose advanced disease and aid in therapy selection without the need for a biopsy

News | Prostate Cancer

PSMA PET/CT Waives the Need for Pre-imaging Biopsy in Elderly Patients

August 15, 2023 — In elderly patients with suspected prostate cancer, PSMA PET/CT can diagnose advanced disease and aid ...

August 15, 2023

FDA-approved generic for MRI procedures is fully substitutable for Gadavist

News | Contrast Media

Fresenius Kabi Further Expands Radiology Portfolio with Launch of Gadobutrol Injection

August 8, 2023 — Fresenius Kabi announced it has launched Gadobutrol Injection, a generic substitute for the contrast ...

August 08, 2023

News | Radiation Therapy

RayCare in Clinical Use with CyberKnife at Lausanne University Hospital (CHUV) in Switzerland

August 3, 2023 —RaySearch Laboratories AB announced that Lausanne University Hospital (CHUV), Switzerland, has treated ...

August 03, 2023

A collaboration to advance development of a fibroblast activation protein (FAP)-targeted PET diagnostic compound for a broad array of epithelial-derived cancers.

News | Radiopharmaceuticals and Tracers

Ratio Therapeutics, In Collaboration with Lantheus and PharmaLogic, Announce First Patient Dosed in Phase I Study Evaluating a Novel FAP-Targeted Radiopharmaceutical for PET Imaging

July 25, 2023 — Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative ...

July 25, 2023

Positron Corporation has entered an Novation Agreement with Shenyang Intelligent Neuclear Medical Technology Co, LTD (Intelligent Neuclear Medical), a wholly owned subsidiary of Neusoft Medical Systems (Neusoft.

News | PET-CT

Positron Corporation Enters New Manufacturing & Components Supplier Cooperative with Neusoft Medical Systems Subsidiary for New PET-CT Device

July 25, 2023 — Positron Corporation, a leading molecular imaging medical device company, is pleased to announce that ...

July 25, 2023

NorthStar’s non-carrier added (n.c.a.) Ac-225 to be used in Bayer’s radiopharmaceutical programs

News | Molecular Imaging

NorthStar Medical Radioisotopes Executes Supply Agreement with Bayer for Therapeutic Radioisotope Actinium-225 (Ac-225)

July 18, 2023 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

July 18, 2023

With uMI Panorama, United Imaging Continues to Push the Envelope on Whole-Body System Performance

News | PET-CT

United Imaging Introduces Next-Generation PET/CT Systems and Integrated Molecular Technology Platform at SNMMI

July 12, 2023 — United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment and ...

July 12, 2023

NorthStar’s high purity non-carrier-added (n.c.a.) Ac-225 to be used in advancing Nucleus’ partners radioligand therapies to treat cancer

News | Molecular Imaging

NorthStar Medical Radioisotopes Announces Supply Agreement with Nucleus RadioPharma for Alpha-emitting Therapeutic Radioisotope Actinium-225 (Ac-225)

July 5, 2023 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

July 05, 2023

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) hosted nearly 8,000 physicians, technologists, pharmacists, laboratory professionals, scientists and others at its 2023 Annual Meeting, themed “Eye on the Patient,” held in Chicago, Illinois.

News | SNMMI

SNMMI Keeps “Eye on the Patient” at 2023 Annual Meeting

June 30, 2023 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) hosted nearly 8,000 physicians ...

June 30, 2023